ArticleFrontiers in oncology2025

Case Report: Rare adverse events following CAR-T therapy in patients with relapsed/refractory diffuse large B-cell lymphoma.

Ziniya Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.